Peripheral artery disease is under scrutiny as the number of endovascular interventions has soared. In a field where clinical evidence is sparse, experts are asking how the financial and societal costs of revascularization compare with amputating the problem and whether early detection and treatment could save lives, limbs and perhaps healthcare dollars.
Trial results on same-day discharge for elective implantable cardioverter-defibrillator procedures may reassure centers, but whether the approach lowers cost is anyone’s guess.
A new reimbursement model for cardiac care delivery could launch as early as July 1, 2017—giving cardiologists less than a year to prepare to practice in an environment with more risks and different opportunities. Get engaged now, say the experts.
